A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B
Clinical trial NCT06150014 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06150014
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-07
- Primary completion
- 2025-12-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.